[{"address1": "333 Lakeside Drive", "city": "Foster City", "state": "CA", "zip": "94404", "country": "United States", "phone": "650 574 3000", "fax": "650 578 9264", "website": "https://www.gilead.com", "industry": "Drug Manufacturers - General", "industryKey": "drug-manufacturers-general", "industryDisp": "Drug Manufacturers - General", "sector": "Healthcare", "sectorKey": "healthcare", "sectorDisp": "Healthcare", "longBusinessSummary": "Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, Sunlencs, and Atripla products for the treatment of HIV/AIDS; Veklury, an injection for intravenous use, for the treatment of COVID-19; and Epclusa, Harvoni, Vemlidy, and Viread for the treatment of viral hepatitis. It also offers Yescarta, Tecartus, and Trodelvy products for the treatment of oncology; Letairis, an oral formulation for the treatment of pulmonary arterial hypertension; and AmBisome, a liposomal formulation for the treatment of serious invasive fungal infections. The company has collaboration agreements with Arcus Biosciences, Inc.; Merck Sharp & Dohme Corp.; Pionyr Immunotherapeutics Inc.; Tizona Therapeutics, Inc.; Galapagos NV; Janssen Sciences Ireland Unlimited Company; Japan Tobacco, Inc.; Dragonfly Therapeutics, Inc.; Arcellx, Inc.; Everest Medicines; Merck & Co, Inc.; Tentarix Biotherapeutics Inc.; Marengo Therapeutics; and Assembly Biosciences, Inc. It also has research collaboration, option, and license agreement with Merus N.V. for the discovery of novel dual tumor-associated antigens (TAA) targeting trispecific antibodies. The company has a collaboration with Terray Therapeutics, Inc. to discover and develop small molecule therapies; and LEO Pharma to develop, manufacture, and commercialize the small molecule oral STAT6 program. The company was incorporated in 1987 and is headquartered in Foster City, California.", "companyOfficers": [{"maxAge": 1, "name": "Mr. Daniel P.  O'Day", "age": 60, "title": "Chairman & CEO", "yearBorn": 1965, "fiscalYear": 2024, "totalPay": 7137565, "exercisedValue": 0, "unexercisedValue": 30103994}, {"maxAge": 1, "name": "Mr. Andrew D. Dickinson", "age": 55, "title": "Chief Financial Officer", "yearBorn": 1970, "fiscalYear": 2024, "totalPay": 2729705, "exercisedValue": 5536695, "unexercisedValue": 8763160}, {"maxAge": 1, "name": "Ms. Johanna  Mercier", "age": 54, "title": "Chief Commercial & Corporate Affairs Officer", "yearBorn": 1971, "fiscalYear": 2024, "totalPay": 3169442, "exercisedValue": 0, "unexercisedValue": 12195903}, {"maxAge": 1, "name": "Ms. Erin  Burkhart", "age": 46, "title": "SVP, Controller & Principal Accounting Officer", "yearBorn": 1979, "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Ms. Jacquie  Ross C.F.A.", "title": "Senior Vice President of Treasury and Investor Relations", "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Ms. Keeley  Wettan", "title": "Executive VP and General Counsel of Legal & Compliance", "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Ms. Jyoti K. Mehra", "age": 49, "title": "Executive Vice President of Human Resources", "yearBorn": 1976, "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Linda Slanec Higgins Ph.D.", "age": 63, "title": "Senior Vice President of Research, Innovation & Portfolio", "yearBorn": 1962, "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Flavius  Martin M.D.", "title": "Executive Vice President of Research", "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Ms. Janet  Dorling", "age": 51, "title": "Senior Vice President of Intercontinental Region & Global Patient Solutions", "yearBorn": 1974, "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}], "auditRisk": 9, "boardRisk": 5, "compensationRisk": 4, "shareHolderRightsRisk": 2, "overallRisk": 3, "governanceEpochDate": 1769904000, "compensationAsOfEpochDate": 1735603200, "irWebsite": "http://investors.gilead.com/phoenix.zhtml?c=69964&p=irol-irhome", "executiveTeam": [], "maxAge": 86400, "priceHint": 2, "previousClose": 151.81, "open": 151.89, "dayLow": 151.46, "dayHigh": 156.95, "regularMarketPreviousClose": 151.81, "regularMarketOpen": 151.89, "regularMarketDayLow": 151.46, "regularMarketDayHigh": 156.95, "dividendRate": 3.28, "dividendYield": 2.12, "exDividendDate": 1773360000, "payoutRatio": 0.4661, "fiveYearAvgDividendYield": 3.76, "beta": 0.387, "trailingPE": 22.89217, "forwardPE": 16.100613, "volume": 6785575, "regularMarketVolume": 6785575, "averageVolume": 7422003, "averageVolume10days": 8522400, "averageDailyVolume10Day": 8522400, "bid": 146.6, "ask": 163.55, "bidSize": 2, "askSize": 1, "marketCap": 192280526848, "fiftyTwoWeekLow": 93.37, "fiftyTwoWeekHigh": 157.29, "allTimeHigh": 157.29, "allTimeLow": 0.207031, "priceToSalesTrailing12Months": 6.5306025, "fiftyDayAverage": 130.1722, "twoHundredDayAverage": 117.94565, "trailingAnnualDividendRate": 3.16, "trailingAnnualDividendYield": 0.020815494, "currency": "USD", "tradeable": false, "enterpriseValue": 206317174784, "profitMargins": 0.28903, "floatShares": 1238269800, "sharesOutstanding": 1240679623, "sharesShort": 23684789, "sharesShortPriorMonth": 23154890, "sharesShortPreviousMonthDate": 1767139200, "dateShortInterest": 1769731200, "sharesPercentSharesOut": 0.0191, "heldPercentInsiders": 0.0011999999, "heldPercentInstitutions": 0.92300004, "shortRatio": 3.23, "shortPercentOfFloat": 0.0191, "impliedSharesOutstanding": 1240679623, "bookValue": 18.226, "priceToBook": 8.503237, "lastFiscalYearEnd": 1767139200, "nextFiscalYearEnd": 1798675200, "mostRecentQuarter": 1767139200, "earningsQuarterlyGrowth": 0.224, "netIncomeToCommon": 8510000128, "trailingEps": 6.77, "forwardEps": 9.62572, "lastSplitFactor": "2:1", "lastSplitDate": 1359331200, "enterpriseToRevenue": 7.007, "enterpriseToEbitda": 14.15, "52WeekChange": 0.472494, "SandP52WeekChange": 0.11527538, "lastDividendValue": 0.79, "lastDividendDate": 1765756800, "quoteType": "EQUITY", "currentPrice": 154.98, "targetHighPrice": 174.0, "targetLowPrice": 118.0, "targetMeanPrice": 151.65385, "targetMedianPrice": 155.0, "recommendationMean": 1.64286, "recommendationKey": "buy", "numberOfAnalystOpinions": 26, "totalCash": 10604999680, "totalCashPerShare": 8.546, "ebitda": 14580999168, "totalDebt": 24591998976, "quickRatio": 1.314, "currentRatio": 1.683, "totalRevenue": 29443000320, "debtToEquity": 108.728, "revenuePerShare": 23.668, "returnOnAssets": 0.12516, "returnOnEquity": 0.40655, "grossProfits": 23213000704, "freeCashflow": 6243624960, "operatingCashflow": 10019000320, "earningsGrowth": 0.235, "revenueGrowth": 0.047, "grossMargins": 0.78839993, "ebitdaMargins": 0.49523, "operatingMargins": 0.37401, "financialCurrency": "USD", "symbol": "GILD", "language": "en-US", "region": "US", "typeDisp": "Equity", "quoteSourceName": "Nasdaq Real Time Price", "triggerable": true, "customPriceAlertConfidence": "HIGH", "marketState": "CLOSED", "regularMarketChangePercent": 2.08814, "corporateActions": [], "postMarketTime": 1771030495, "regularMarketTime": 1771016402, "exchange": "NMS", "messageBoardId": "finmb_29002", "exchangeTimezoneName": "America/New_York", "exchangeTimezoneShortName": "EST", "gmtOffSetMilliseconds": -18000000, "market": "us_market", "esgPopulated": false, "fiftyTwoWeekLowChange": 61.609993, "fiftyTwoWeekLowChangePercent": 0.6598478, "fiftyTwoWeekRange": "93.37 - 157.29", "fiftyTwoWeekHighChange": -2.3099976, "fiftyTwoWeekHighChangePercent": -0.014686233, "fiftyTwoWeekChangePercent": 47.2494, "dividendDate": 1767052800, "earningsTimestamp": 1770757200, "earningsTimestampStart": 1776978000, "earningsTimestampEnd": 1776978000, "earningsCallTimestampStart": 1770759000, "earningsCallTimestampEnd": 1770759000, "isEarningsDateEstimate": true, "epsTrailingTwelveMonths": 6.77, "epsForward": 9.62572, "epsCurrentYear": 8.72315, "priceEpsCurrentYear": 17.766518, "fiftyDayAverageChange": 24.8078, "fiftyDayAverageChangePercent": 0.19057679, "twoHundredDayAverageChange": 37.034348, "twoHundredDayAverageChangePercent": 0.31399503, "sourceInterval": 15, "exchangeDataDelayedBy": 0, "averageAnalystRating": "1.6 - Buy", "cryptoTradeable": false, "regularMarketPrice": 154.98, "shortName": "Gilead Sciences, Inc.", "longName": "Gilead Sciences, Inc.", "hasPrePostMarketData": true, "firstTradeDateMilliseconds": 696090600000, "postMarketChangePercent": 0.25810373, "postMarketPrice": 155.38, "postMarketChange": 0.40000916, "regularMarketChange": 3.17, "regularMarketDayRange": "151.46 - 156.95", "fullExchangeName": "NasdaqGS", "averageDailyVolume3Month": 7422003, "displayName": "Gilead Sciences", "trailingPegRatio": 0.2804, "__fetch_time": "2026-02-14"}]